X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Europe

Chemspec Europe 2018 in Cologne closes with a record in visitor numbers

Content Team by Content Team
6th July 2018
in Europe, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The 33rd edition of Chemspec Europe, International Exhibition for Fine and Speciality Chemicals, endedafter two successful show days with record visitor numbers. From

20 to 21 June 2018, a total of 4,202 trade visitors came to the exhibition grounds of the Koelnmesse in Cologne, Germany, where international experts of the fine and speciality chemicals industry met for Europe’s leading exhibition. These figures represent an increase of visitor numbers by nearly 9% compared to last year’s show in Munich.

The results of Chemspec Europe’s 33rd edition are very gratifying: With a total of 358 exhibitors and 6,724 attendees from all over the world, the specialised industry event was able to further increase its overall attendance figure (exhibitors, visitors, press and conference delegates) compared to the 2017 show in Munich.This year’s Chemspec Europe attracted a total of 4,202 trade visitors which represents a plus in visitors ofnearly9%.

“We are very pleased that we could further increase the Chemspec Europevisitor numbers. The sustainable growth of the exhibition reflects the overall positive industry outlook where a reliable network is absolutely crucial.For international industry experts, Chemspec Europe has become an absolute must-attend event in the trade fair calendar if you want to stay up-to-date with current trends, like bio-based chemicals, flexible manufacturing processes or strategic collaborations, and meet top decision-makersin the fine and speciality chemicals industry”, said Liljana Goszdziewski, Exhibition Director of Chemspec Europe, on behalf of the organisers, Mack Brooks Exhibitions.

At Chemspec Europe 2018, the 358 exhibitors from 27 countries showcased a wide variety of fine and speciality chemicals for a large range of applications on a net floor space of 6,075m2. The major European exhibitor countries were Germany, the UK, France, Belgium and Switzerland. Non-European exhibitors mainly came from China, India and the USA.

Visitors to Chemspec Europe 2018 came from a total of 66 countries; predominantly from Germany (39%), followed by the UK, the Netherlands,Switzerland, France, India, Italy, China, Belgium, Spainand the USA.
The preliminary results of the exhibition survey show that the majority of visitors came from the following industries: Pharma, agriculture, plastics and polymers, paints and coatings, research and development, cosmetics, toiletries and personal care, petrochemicals, contract and toll manufacturing, adhesives and sealants as well as water treatment. The majority of visitors were manufacturers, distributors, raw material suppliers or equipment suppliers and work in research and development or for consulting firms. The main responsibilities of the visitors within their companies were senior management,purchasing and procurement, research and development, and marketing.

Visitors were mainly interested in the following products and services: Chemical intermediates, general chemicals,industrial chemicals, pharmaceuticals, agrochemicals, APIs, polymers,custom synthesis, green chemicals and catalysts.

Broadconference programmevery well received
Visitors to this year’s Chemspec Europe had the opportunity toattend several conferences and workshops covering many different topics. In cooperation with renowned partner organisations, the conferences did not only offer insightsinto trends and prospects, but also encouraged exchange and networking with international industry colleagues.

The conference programme included the “Agrochemical Outlook Conference”, sponsored byAgrow Magazine,as well as the“Innovative Startups”conference,organised incooperation with BCNP Consultants,which included short presentations of young startups on the topic“New Paths to Fine and Specialty Chemicals”.In the Pharma Lecture Theatre,visitors could listen to lectures about trends and challenges in the pharma industry, including a presentation given by Dr MagidAbou-Gharbia, Moulder Center for Drug Discovery Research, andthe“Pharma Outsourcing Best Practices Panel”.Furthermore, the conference programme included the two day“RSC Symposium” of the Royal Society of Chemistry, the“Regulatory Services Conference”,organised byREACHReady,as well as the“Crop Protection & Fine Chemicals Forum”held by EFCG (The European Fine Chemicals Group).

High re-booking rate among exhibitors for Chemspec Europe 2019 in Basel
An initial evaluation of the exhibition survey revealed that exhibitors, visitors and conference delegates were highly satisfied with the show. A large majority of exhibitors already secured their stands for Chemspec Europe 2019whilst on-site. As a result, approximately 75% of the total net floor space is already booked and reserved for the upcoming exhibition.

Chemspec Europe 2019will take place from 26 to 27 June 2019 in hall 1.0 of Messe Basel, Switzerland. The Basel region is one of Europe’s major hubs for the fine and speciality chemicals industry and borders three of Europe’s strongest countries in this sector – Germany, France and Switzerland.

Previous Post

Bruker Launches New Sierra™ SPR-32 High-Performance Surface Plasmon Resonance System at SLAS Europe 2018

Next Post

Anima Biotech announces an exclusive collaboration with Lilly for the discovery and development of translation inhibitors of several protein targets

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post

Anima Biotech announces an exclusive collaboration with Lilly for the discovery and development of translation inhibitors of several protein targets

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In